Buprenorphine with naloxone sublingual tab 2 mg with naloxone 0.5 mg: Supply issue resolved
There was a supply issue affecting buprenorphine with naloxone (pharmacode 2574004 - sublingual tab 2 mg with naloxone 0.5 mg)
Affected product
The supplier experienced an out of stock of:
- Chemical: Buprenorphine with naloxone
- Presentation: Tab sublingual 2 mg with naloxone 0.5 mg
- Brand: Buprenorphine Naloxone BNM
- Pharmacode: 2574004
- Subsidy: $11.76
- Measure / Qty: per 28
The 8mg/2mg tablet (Pharmacode 2574012) is not affected.
Schedule listing for buprenorphine with naloxone(external link)
Expected resolution
A shipment has arrived in Aotearoa New Zealand and has been cleared for release. Stock is being distributed to wholesalers on the 24 October 2024. Wholesalers will prioritise the release of this product to pharmacies.
Information for pharmacists
You may want to review your stock holdings of the 2 mg / 0.5 mg strength of buprenorphine with naloxone to see whether this issue will impact your patients. If there are potential issues, you may wish to discuss the best course of action for your patients with the prescriber / AOD case manager.
We apologise for the any additional work this issue might cause.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)